Key weight loss results at 48 weeks by group: Response rates at 48 weeks (12 mg dose): 100% achieved greater than or equal to 5% weight loss 93% achieved greater than or equal to 10% weight loss 83% achieved greater than or equal to 15% weight loss The cardiometabolic improvements were also significant, with reductions in blood pressure, triglycerides, LDL cholesterol, HbA1c, fasting glucose, and fasting insulin across all dose groups
GLP-1 Users for Weight Management command a 31.80% share in the target consumer segment, driven by the widespread adoption of GLP-1 receptor agonists specifically for obesity and weight management and maintain nutritional balance
J Chin Cereals Oils Assoc 28:8086 Mister M, Noris M, Szymczuk J, Azzollini N, Aiello S, Abbate M, Trochimowicz L, Gagliardini E, Arduini A, Perico N, Remuzzi G (2002) Propionyl-l-carnitine prevents renal function deterioration due to ischemia/reperfusion
Scared of throwing away a valuable heirloom